The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Oncolytics Biotech Inc closed at $0.41.

Shares have lost 7.95% over the last five days, but have gained 5.19% over the last year to date. This security has underperformed the S&P TSX by 49.60% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.12
Updated at previous session's close. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue------0
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4434
Selling / general / administrative0000
Research & development3222
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1111
Operating income-4-4-3-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-3-3-4
Income after tax-4-3-3-4
Income tax, total0000
Net income-4-3-3-4
Total adjustments to net income--------
Net income before extra. items-4-3-3-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-3-3-4
Inc. avail. to common incl. extra. items-4-3-3-4
Diluted net income-4-3-3-4
Dilution adjustment0000
Diluted weighted average shares118118118115
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.03-0.02-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.03-0.02-0.03